Novo Nordisk NVO announced plans to advance amycretin, for weight management, into late-stage development. Amycretin is being ...

Nonalcoholic fatty liver disease (NAFLD) was linked to elevated liver enzymes in type 2 diabetes mellitus (T2DM) in a recent ...

Discover expert tips from an obesity medicine doctor on effective and sustainable ways to approach weight loss for type 2 ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...

Eli Lilly’s LLY key top-line drivers are its GLP-1 medicines, Mounjaro for type II diabetes and Zepbound for obesity. Both ...

Eli Lilly joins up with Camurus to make long-acting versions of the pharma's obesity and diabetes drugs, joining the industry ...

Obesity is not only a lifestyle issue but a major risk factor for cancer in men. With rising obesity rates in India, it’s ...

This expert-backed guide compares bariatric surgery and weight loss drugs highlighting long-term outcomes health benefits and ...

Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with ...

Rep. Vern Buchanan (R-FL) is introducing a bill to reduce the risk of early-onset diabetes and obesity in the U.S. military amid increasing scrutiny on the subject. The ...

Semaglutides, which are used to treat type 2 diabetes and obesity, were the most-sold medication in Finland last year, ...